Zimbabwe has declined a major US health deal valued at 367 million US dollars (272 million pounds) over five years over Washington's request for sensitive information.
The decision came to light after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government representative later stated that the US was demanding access to biological samples for scientific study and profit but refused to share the benefits from future treatments.
"We will now turn to the difficult and regrettable process of ending our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more dialogue to secure a agreement agreeable to all parties so the nation's critical HIV treatment initiative can be sustained.
Broader Context
This rejection follows a similar situation in Kenya, where a high court halted a similar health funding agreement after legal challenges were raised about the safety of citizens' health data.
After resuming office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to boost openness and accountability.
Based on reports, 16 nations in Africa have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment through American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"Put simply, our nation would provide the basic resources for scientific discovery with no assurance that the end products would be available to our population should a new disease outbreak emerge."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures already set up through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to deal with potential global health emergencies.
"This framework is intended to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage continued dialogue with our US partners on how future co-operation could be designed in a way that honours the sovereignty and dignity of both nations."
Health Experts Response
Medical experts stated it acknowledged the government's concerns, but urged that talks should continue considering a large portion of the country's HIV programmes relied on international support.
"Where specific concerns arise, including those relating to information security or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," it said.
This impasse highlights the complex tensions between receiving much-needed international aid and safeguarding a country's data in an ever more interconnected world.